These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29054183)

  • 1. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.
    Patil D; Lanjewar C; Vaggar G; Bhargava J; Sabnis G; Pahwa J; Phatarpekar A; Shah H; Kerkar P
    Indian Heart J; 2017; 69(5):600-606. PubMed ID: 29054183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry.
    Nelson AJ; Inohara T; Rao SV; Kaltenbach LA; Wojdyla D; Wang TY
    Am Heart J; 2023 Jan; 255():117-124. PubMed ID: 36220357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness-based reimbursement of elective invasive coronary procedures in low- and middle-income countries: Preliminary assessment of feasibility in India.
    Karthikeyan G; Shirodkar U; Lochan MR; Birch S
    Natl Med J India; 2017; 30(1):11-14. PubMed ID: 28731000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of percutaneous coronary interventions performed according to the appropriate use criteria for coronary revascularization.
    Barbash IM; Dvir D; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2013; 14(6):316-20. PubMed ID: 23988721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost Savings Associated With Implementation of Peer-Reviewed Appropriate Use Criteria for Percutaneous Coronary Interventions.
    Puri P; Carroll J; Patterson B
    Am J Cardiol; 2016 Apr; 117(8):1289-93. PubMed ID: 26899491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.
    Chen SH; Ho KK; Gannon SA; Thyagarajan B; Chakrabarti AK; Potter BJ; Singla A; Piccirillo BJ; Meduri CU; Cutlip DE
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):E74-9. PubMed ID: 26699241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying appropriate-use criteria to cardiac revascularisation in India.
    Sood N; Ugargol AP; Barnes K; Mahajan A
    BMJ Open; 2016 Mar; 6(3):e010345. PubMed ID: 27029773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
    Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
    Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes.
    Chui PW; Parzynski CS; Ross JS; Desai NR; Gurm HS; Spertus JA; Seto AH; Ho V; Curtis JP
    J Am Heart Assoc; 2019 Jan; 8(2):e010373. PubMed ID: 30642222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing.
    Inohara T; Kohsaka S; Miyata H; Ueda I; Ishikawa S; Ohki T; Nishi Y; Hayashida K; Maekawa Y; Kawamura A; Higashi T; Fukuda K
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1000-9. PubMed ID: 25234672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of PCI Appropriateness in the Long-Term Outcomes of Consecutive Patients Treated With Second-Generation Drug-Eluting Stents.
    Seixas AC; Sousa A; de Ribamar Costa J; Costa Moreira A; Costa R; Damiani L; Campos Neto C; Maldonado G; Cano M; Sousa JE
    J Invasive Cardiol; 2017 Sep; 29(9):290-296. PubMed ID: 28623668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional to tertiary inter-hospital transfer versus in-house percutaneous coronary intervention in acute coronary syndrome.
    Javat D; Heal C; Banks J; Buchholz S; Zhang Z
    PLoS One; 2018; 13(6):e0198272. PubMed ID: 29927947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort.
    Alcock RF; Yong AS; Ng AC; Chow V; Cheruvu C; Aliprandi-Costa B; Lowe HC; Kritharides L; Brieger DB
    Int J Cardiol; 2013 Aug; 167(4):1343-6. PubMed ID: 22534045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program.
    Bradley SM; Bohn CM; Malenka DJ; Graham MM; Bryson CL; McCabe JM; Curtis JP; Lambert-Kerzner A; Maynard C
    Circulation; 2015 Jul; 132(1):20-6. PubMed ID: 26022910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.
    Thomas MP; Parzynski CS; Curtis JP; Seth M; Nallamothu BK; Chan PS; Spertus JA; Patel MR; Bradley SM; Gurm HS
    PLoS One; 2015; 10(9):e0138251. PubMed ID: 26379053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National interventional council data for the year 2018-India.
    Arramraju SK; Janapati RK; Sanjeeva Kumar E; Mandala GR
    Indian Heart J; 2020; 72(5):351-355. PubMed ID: 33189193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, Outcomes and Cost Implications of Patients Undergoing Same Day Discharge After Elective Percutaneous Coronary Intervention in Australia.
    Liew S; Dinh D; Liew D; Brennan A; Duffy S; Reid C; Lefkovits J; Stub D;
    Heart Lung Circ; 2020 Aug; 29(8):e185-e193. PubMed ID: 31791887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of coronary revascularization appropriateness for non-acute coronary syndrome cases under the 2017 update vs the 2012 appropriate use criteria.
    Case BC; Geiser KM; Torguson R; Pichard AD; Satler LF; Waksman R; Ben-Dor I
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):620-625. PubMed ID: 30280475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011).
    Kim LK; Feldman DN; Swaminathan RV; Minutello RM; Chanin J; Yang DC; Lee MK; Charitakis K; Shah A; Kaple RK; Bergman G; Singh H; Wong SC
    Am J Cardiol; 2014 Oct; 114(7):1003-10. PubMed ID: 25118124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of barriers and facilitators in the implementation of appropriate use criteria for elective percutaneous coronary interventions: a qualitative study.
    Lambert-Kerzner A; Maynard C; McCreight M; Ladebue A; Williams KM; Fehling KB; Bradley SM
    BMC Cardiovasc Disord; 2018 Aug; 18(1):164. PubMed ID: 30103677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.